Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00848497 · ClinicalTrials.gov registry record · Early Phase 1
Testosterone for Penile Rehabilitation After Radical Prostatectomy
A Early Phase 1 study, sponsored by Mohit Khera.
- Terminated
- Registry status
- Early Phase 1
- Development phase
- 3
- Enrollment target
NCT00848497 is a Early Phase 1 study that was terminated before completion, run by Mohit Khera. The registered enrollment target is 3 participants.
The verdict
NCT00848497, a Early Phase 1 study, was terminated before completion, sponsored by Mohit Khera.
- TERMINATED
- Registry status
- Early Phase 1
- Development phase
- 3 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effectiveness of testosterone replacement therapy (TRT) in men following surgery to remove the prostate in improving erectile function. Subjects will be randomized (like flipping a coin) to one of two groups. One group will receive Testim® (testosterone gel) 5 g per day plus Viagra 25 mg every night and the other will receive Placebo-Testim® 5 g per day plus Viagra 25 mg every night. Subjects will begin drug treatment 3 months after the initial screening visit and will take study drug for 3 months only. Participation will end at the end of the 6-month visit.
Interventions
- DRUG Testim®
- OTHER Placebo Testim®
- DRUG Viagra®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2007-11 |
| Est. Completion | 2013-03 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00848497
The ClinicalTrials.gov registry entry for NCT00848497 describes a study currently listed as terminated, categorized as Early Phase 1. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mohit Khera, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Testim® is the first listed.
NCT00848497 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00848497 about?
NCT00848497 is a clinical study titled "Testosterone for Penile Rehabilitation After Radical Prostatectomy". The purpose of this study is to determine the effectiveness of testosterone replacement therapy (TRT) in men following surgery to remove the prostate in improving erectile function. Subjects will be randomized (like flipping a coin) to one of two groups. One group will receive Testim® (testosterone ...
What is the current status of trial NCT00848497?
This trial is currently terminated. It is a Early Phase 1 study. The enrollment target is 3 participants. The study started on 2007-11. Estimated completion is 2013-03.
What interventions are being tested in trial NCT00848497?
The interventions under investigation include: Testim® (DRUG), Placebo Testim® (OTHER), Viagra® (DRUG).
Who is sponsoring clinical trial NCT00848497?
This trial is sponsored by Mohit Khera, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.